Wang, BaoXia – Trademark Portfolio

Entity Type: 01

Wang, BaoXia holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 25 (Clothing) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include COTIZO, FIZANU, ROENWI, TIZODU, and ZISONU. The owner is based in Linyi.

No.93,Fuqian St,Caozhuang Town,

Linshu County,Shandong

Linyi 276700 , CN

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ROENWI
ROENWI
Registered 2020
TIZODU
TIZODU
Registered 2020
COTIZO
COTIZO
Registered 2020
ZISONU
ZISONU
Registered 2020
FIZANU
FIZANU
Registered 2020

Trademark Classifications

Wang, BaoXia's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (4 filings)

Surgical, medical, dental and veterinary apparatus and instruments

25
Clothing (1 filing)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does Wang, BaoXia have?

Wang, BaoXia has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.

What trademark classes does Wang, BaoXia file in?

Wang, BaoXia files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 25 (Clothing). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Wang, BaoXia's most well-known trademarks?

Wang, BaoXia's registered trademark portfolio includes well-known marks such as COTIZO, FIZANU, ROENWI, TIZODU, and ZISONU. These are among 5 currently registered trademarks in the portfolio.

What is Wang, BaoXia's trademark registration success rate?

Wang, BaoXia has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.